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ChondrogenesisNatural biomaterials such as collagen show promise in tissue engineering applications due to their
inherent bioactivity. The main limitation of collagen is its low mechanical strength and somewhat
unpredictable and rapid degradation rate; however, combining collagen with another material, such as
chitosan, can reinforce the scaffold mechanically and may improve the rate of degradation.
Additionally, the high cost and the risk of prion transmission associated with mammal-derived collagen
has prompted research into alternative sources such as marine-origin collagen. In this context, the overall
goal of this study was to determine if the incorporation of chitosan into collagen scaffolds could improve
the mechanical and biological properties of the scaffold. In addition the study assessed if collagen,
derived from salmon skin (marine), can provide an alternative to collagen derived from bovine tendon
(mammal) for tissue engineering applications. Scaffold architecture and mechanical properties were
assessed as well as their ability to support mesenchymal stem cell growth and differentiation. Overall,
the addition of chitosan to bovine and salmon skin-derived collagen scaffolds improved the mechanical
properties, increasing the compressive strength, swelling ratio and prolonged the degradation rate.
Mesenchymal stem cell (MSC) attachment and proliferation was most improved on the bovine-derived
collagen scaffold containing a 75:25 ratio of collagen:chitosan, and when MSC osteogenic and chondro-
genic potential on the scaffold was assessed, a significant increase in calcium production (p < 0.001) and
sulfated glycosaminoglycan (sGAG) production (p < 0.001) was observed respectively. Regardless of
chitosan content, the bovine-derived collagen scaffolds out-performed the salmon skin-derived collagen
scaffolds, displaying a larger pore size and higher percentage porosity, more regular architecture, higher
compressive modulus, a greater capacity for water uptake and allowed for more MSC proliferation and
differentiation. This versatile scaffold incorporating the marine biomaterial chitosan show great potential
as appropriate platforms for promoting orthopaedic tissue repair while the use of salmon skin-derived
collagen may be more suitable in the repair of soft tissues such as skin.
Statement of Significance
Collagen is commonly used in tissue engineering due to its biocompatibility; however, it has low
mechanical strength and an unpredictable degradation rate. In addition, high cost and risk of prion trans-
mission associated with mammalian-derived collagen has prompted research into alternative collagen
sources, namely, marine-derived collagen. In this study, scaffolds made from salmon-skin collagen were
compared to the more commonly used bovine-derived collagen with a focus on orthopaedic applications.to col-
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lagen scaffolds on mechanical and biological fuTo improve the mechanical properties of these scaffolds, another marine biomaterial, chitosan, was added
to produce scaffolds with increased mechanical stability. The collagen-chitosan composites were also
shown to support mesenchymal stem cell differentiation towards both bone and cartilage tissue. This
multi-functional scaffold therefore has potential in both bone and cartilage regeneration applications.
 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.1. Introduction
Biomaterial scaffolds for orthopaedic tissue engineering
applications should be capable of integrating with native tissue,
allowing for cell infiltration and proliferation, and to degrade at a
rate proportional to new tissue formation, all without causing an
immunological response. The material composition of the scaffold
plays an important role in directing cell behaviour; natural
biomaterials such as collagen show promise due to their inherent
bioactivity [1–4]. The mechanical properties of biomaterials for
orthopaedic applications must also be considered; in seminal work
by Engler and colleagues, it was shown that mesenchymal stem
cells (MSCs) differentiate toward different phenotypes depending
on the stiffness of the substrate upon which they are seeded [5].
As well as influencing cell behaviour, scaffolds must be strong
enough to withstand physical manipulation subjected during
implantation and be straight-forward to fabricate, sterilize and
shape to the size required [6]. The main limitation of natural
materials, such as collagen, in orthopaedic tissue engineering
applications, is their low mechanical strength and somewhat
unpredictable degradation rate; however combining two or more
materials can reinforce the scaffold mechanically and may slow
the rate of degradation.
Chitosan is a biocompatible, biodegradable polysaccharide
derived from chitin, which can be isolated from many marine spe-
cies [7]. The most common source of chitin is crab and shrimp
exoskeletons, of which at least 2.3 million metric tons are pro-
duced each year as food waste [8]. Chitosan is a very interesting
material as it can be processed into hydrogels [9,10], nanofibers
[11], beads [12], microparticles [13], nanoparticles [14–16] and
porous scaffolds [17–19] and has been used in a wide range of
tissue engineering applications such as in wound healing [20],
and in drug and gene delivery [16,21–24]. Of particular interest
in orthopaedic tissue engineering, chitosan has been shown to
promote MSC osteogenesis [25] and, being a linear polysaccharide,
has an analogous molecular structure to hyaluronic acid, a non-
sulfated glycosaminoglycan which is a major component of articu-
lar cartilage, and has been shown to support MSC chondrogenesis.
Collagen is the most abundant protein found in the human
body, serving as the major component of the extracellular matrix
[4,26,27]. It is biocompatible and biodegradable and readily allows
for cell adhesion, proliferation and differentiation [28]. For this rea-
son collagen is in widespread use in tissue engineering research,
however, it has low mechanical strength and rapid degradation
rate, which are limiting its use commercially. Cross-linking meth-
ods can increase the mechanical properties of collagen however
the incorporation of another material, forming a composite has
shown the most promise in improving the scaffolds characteristics
[29–31]. Due to the interesting properties of chitosan outlined
above, the main aim of this study was to investigate the potential
of collagen-chitosan composite scaffolds for orthopaedic tissue
engineering applications.
A further caveat in choosing biomaterials for tissue engineering
is the source; as collagen is such a ubiquitous material, it can be
extracted from numerous sources, most commonly bovine and
porcine connective tissue such as skin and tendon. However, while
mammalian-derived tissues are subject to extensive processing toet al., Multifunctional biomater
nctionality, Acta Biomater. (201reduce risk of disease transmission and immunogenicity, there
remain concerns about transmission of prions such as
Creutzfeldt-Jakob Disease (CJD), although there have been no
reports of this to date [32–35]. Religious restriction is also an
important issue as three major religions; Judaism, Islam and
Hinduism prohibit the use of products derived from either bovine
or porcine origin [36]. For these reasons, there has been interest in
alternative sources of collagen. While recombinant technology can
be used to make collagen, it is extremely expensive and yields are
low and inefficient for most tissue engineering applications [37].
Alternatively, marine-derived collagen is an easily accessible
source of collagen and can be obtained from many different
sources including fish skin, jellyfish and marine sponges [38–40].
As up to 75% of fish weight is discarded as a food waste, it is
possible to obtain large amounts of collagen cheaply [41]. One
drawback to marine-derived collagen is that it has lower hydrox-
yproline content than the more commonly used bovine-derived
collagen. Hydroxyproline functions to stabilise the collagen triple
helix conformation and a high hydroxyproline content indicates
greater thermal stability [42]. The denaturation temperature of
marine-derived collagen is thus reported to be approximately
40 C [41] whereas bovine-derived collagen has a reported denat-
uration temperature of 95 C [43].
The objectives of this study was thus to investigate the effect of
the incorporation of chitosan on the morphological and mechanical
properties of collagen scaffolds and also to determine if marine-
derived collagen, isolated from salmon skin, might serve as a viable
alternative to mammal-derived collagen, isolated from bovine ten-
don, in tissue engineering applications. In addition, the potential of
the resultant collagen-chitosan composite scaffold to enhance both
MSC-mediated osteogenesis and chondrogenesis was assessed.2. Materials and methods
All materials were provided by Sigma Aldrich, Ireland unless
otherwise stated.2.1. Isolation of collagen from salmon skins
Salmon skins were obtained from a local market and kept
frozen until use. Scales and muscle were removed and skins were
further washed with water and cut into pieces of about 2  2 cm.
Fats were removed from salmon skins by immersion in 10%
ethanol for 48 h, under stirring (with change of solution at least
twice a day). Salmon skins were then treated with 0.1 M NaOH
(1:10 w/v), during 3  2 h, to remove non-collagenous proteins
as described previously [41,44–46]. After thorough washing with
water, salmon skins were dissolved in 0.5 M acetic acid (HOAc)
(1:10 w/v), during 72 h, under stirring. The resulting mixture was
centrifuged and the supernatant, containing the acid soluble colla-
gen, was further vacuum filtered to remove non-soluble impuri-
ties. Salmon-skin collagen was recovered by salting out and after
centrifugation; collagen was resuspended in 0.5 M HOAc, dialysed
against 0.1 M HOAc and freeze-dried until further use. All the
extraction procedure was conducted at 4 C and the resultingials from the sea: Assessing the effects of chitosan incorporation into col-
6), http://dx.doi.org/10.1016/j.actbio.2016.07.009
R.M. Raftery et al. / Acta Biomaterialia xxx (2016) xxx–xxx 3marine salmon skin collagen is consistent with type 1 collagen
(Supplementary Fig. 1).
2.2. Fabrication of collagen and collagen-chitosan scaffolds
Bovine tendon collagen (Integra Life Sciences, USA) and marine
salmon skin collagen were used to make a series of collagen-based
scaffolds either containing collagen alone or as compositeswith chi-
tosan derived from crustacean shells. Bovine and salmon-derived
collagen slurries were made by adding 1.8 g of collagen to 360 mL
of 0.5 M HOAc and blended at 15,000 rpm for 90 min using an over-
head blender (Ultra Turrax T18 Overhead Blended, IKA Works Inc.,
USA) at a constant temperature of 4 C [47]. Medium molecular
weight chitosan (Mw 110–160 kDa; DD 75–85%), purchased from
FMC Biopolymer, Norway, was added to collagen in ratios of 100:0,
90:10, 75:25 and 50:50 collagen:chitosan. Chitosan was first dis-
solved in 0.5 M HOAc by stirring for 3 h. The appropriate amount
of collagen was then added to the dissolved chitosan and blended
at 15,000 rpm for 90 min as described above. Each slurry was
degassed under a vacuum prior to freeze-drying (Advantage EL,
Vis-Tir Co., Gardiner NY) to a final temperature of -40 C using a pre-
viously optimised freeze-drying process [47,48]. Collagen and chi-
tosan interact via electrostatic interactions and hydrogen bonding
as has been shown previously [49–51], and by adding chitosan to
collagen slurries, the compressive strength increased 2-fold. How-
ever, as the scaffolds were made to be used in bone and cartilage
applications, the scaffolds were further sterilised and cross-linked
dehydrothermally (DHT) at 105 C for 24 h at 0.05 bar in a vacuum
oven (Vacucell 22; MMM, Germany) [52], followed by chemical
cross-linking using a mixture of 6 mMN-(3-Dimethylaminopro
pyl)-N0-ethylcarbodiimide hydrochloride (EDC) and 5.5 mM
N-Hydroxysuccinimide (NHS). Both DHT and EDC cross-linking
methods act on lysine, arginine, serine, glutamic acid, aspartic acid
and threonine amino acid residues on collagen [52,53]. While
chitosan also contains amino groups, the lack of carboxyl groups
indicates that EDCdoes not affect chitosan [54]. Cylindrical scaffolds
(10 mm diameter), cut using a biopsy punch, were used in
experiments.
2.3. Effect of chitosan incorporation on scaffold morphology and
architecture
2.3.1. Effect of chitosan incorporation on scaffold pore size
Pore size analysis was carried out using a histological technique
previously described [55]. 10 mm scaffold samples were obtained
from three locations on each scaffold sheet. The samples were
embedded in JB-4 glycolmethacrylate (Polysciences Europe,
Eppelheim, Germany) and serially sectioned longitudinally and
transversely on a microtome (Leica RM 2255, Leica, Germany) to
give 10 lm thick sections, which were stained with toluidine blue.
Digital images were captured at 10 x magnification using an optical
microscope (Eclipse 90i, Nikon, Japan) and a digital camera (DS Ri1,
Nikon, Japan). Pore size analysis was carried out on MATLAB
(MathWorks Inc, MA, USA) using a pore topology analyser
developed in conjunction with the Sigmedia Research Group in
the Electrical Engineering Department at Trinity College Dublin,
Ireland [48]. The programme transformed the images into binary
form and calculated the average pore radii based on best-fit
elliptical lengths.
2.3.2. Effect of chitosan incorporation on scaffold porosity
Total percentage porosity (P) of the scaffolds was measured
according to the following equation
Porosity ð%Þ ¼ q scaffold
q material
 100 ð2:1ÞPlease cite this article in press as: R.M. Raftery et al., Multifunctional biomater
lagen scaffolds on mechanical and biological functionality, Acta Biomater. (201where q material is the density of the material of which the scaffold
is fabricated and q scaffold is the apparent density of the scaffold
measured by dividing the weight by the volume of the scaffold.
2.3.3. Effect of chitosan incorporation on scaffold architecture
In order to examine the effect of chitosan incorporation on
scaffold architecture, scanning electron microscopy was carried
out. Scaffolds were manufactured as described in Section 2.5.1.
The samples were dried before being mounted onto metallic studs
using carbon cement and sputtered with gold/palladium alloy and
imaged using a Zeiss Ultra Plus scanning electron microscope
(SEM) (Zeiss, Germany).
2.4. Effect of chitosan incorporation on scaffold mechanical properties
2.4.1. Effect of chitosan incorporation on scaffold bulk compressive
modulus
Uni-axial, unconfined compressive testing was carried out to
determine the compressive elastic modulus of each scaffold with
diameter of 10 mm and a height of 4 mm. Samples were pre-
hydrated in phosphate buffered saline (PBS) for 1 h prior to testing.
A mechanical testing machine (Z050, Zwick-Roell, Germany) was
fitted with a 5 N load cell and used in the procedure. The pre-
hydrated samples were immersed in PBS throughout the tests.
The tests were conducted in triplicate for each scaffold type at a
strain rate of 10% per minute. Stress was calculated from scaffold
surface area and applied force, whilst strain was calculated from
displacement of the scaffolds in relation to the original thickness.
The compressive modulus was defined based on the slope of a
linear fit to the stress-strain curve over 2–10% strain.
2.4.2. Effect of chitosan incorporation on scaffold swelling ratio
The scaffold swelling ratio, or ability to retain water, is an
important mechanical property as higher swelling ratios is associ-
ated with increased cell adhesion and infiltration. The function of
glycosaminoglycans in orthopaedic tissue is also to retain water,
which increases the compressive strength of the structure. To
assess if chitosan can increase the swelling ratio of collagen scaf-
folds, dry scaffolds were first weighed (d) before being hydrated
in PBS for 24 h at room temperature. After removal of excess sur-
face water with filter paper, the wet scaffolds (w) were weighed
again. The experiment was done in triplicate for each type of
scaffold and the swelling ratio of the scaffolds was calculated using
the following equation;
Swelling Ratio ¼ w d
d
ð2:2Þ
where w = weight of wet scaffold and d = weight of dry scaffold
2.4.3. Effect of chitosan incorporation on scaffold degradation rate
It is hypothesised that the addition of chitosan to the collagen
scaffold will improve the degradation characteristics of the scaf-
fold. To test this hypothesis, the scaffolds were incubated at
37 C for 28 days in serum-containing media in an attempt to repli-
cate physiological conditions. After 28 days, samples were
removed from the medium, rinsed with distilled water, lyophilized
and weighed. The experiment was done triplicate for each scaffold
type. The total percentage of scaffold remaining was calculated.
Using the following equation;




where d0 = weight of dry scaffold at day 0 and d28 = weight of dry
scaffold at day 28.ials from the sea: Assessing the effects of chitosan incorporation into col-
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2.5.1. Cell culture
Primary rat MSCs were cultured in Dulbecco’s modified eagles
medium (DMEM) supplemented with 10% foetal bovine serum
(FBS) (Labtech, UK), 100 U/mL penicillin/streptomycin, 2 mM glu-
tamax (Gibco- Biosciences, Ireland), 1 mM L-glutamine and 1%
non-essential amino acids (Gibco-Biosciences, Ireland). Scaffolds
of 10 mm in diameter and 4 mm in height were placed in 24
well-plates and seeded with 5  105 MSCs. Supplemented DMEM
growth medium was added to each well and the scaffolds were
incubated at 37 C with 5% CO2 for 14 and 28 days with media
changes every 3 days.
2.5.2. Quant-iT dsDNA PicoGreen assay for cell viability
DNA quantification was carried out using a Quant-iTTM Pico-
Green dsDNA kit (Invitrogen, UK). After 14 and 28 days in culture,
media was removed from the wells and the scaffolds were placed
in tubes containing 1 mL of lysis buffer. The samples then under-
went three freeze-thaw cycles at 80 C before the assay was per-
formed as per manufacturer’s instructions. The DNA concentration
was determined using a standard curve.
2.6. Assessment of potential of collagen chitosan scaffold to support
MSC osteogenesis
2.6.1. Osteogenic cell culture
MSCs were cultured and seeded onto scaffolds (10 mm X 4 mm)
as described in Section 2.5.1. After 7 days of culture in supple-
mented DMEM growth media, growth media was replaced with
osteogenic media which contains DMEM supplemented with 10%
FBS (Labtech, UK), 1% penicillin/streptomycin, 10 mM b-
glycerophosphate, 50 lm ascorbic acid 2-phosphate and 100 nM
dexamethasone. Media was replaced every 3 days for the duration
of the culture period (14 and 28 days).
2.6.2. Alizarin red staining for calcium
After 14 and 28 days in osteogenic media, samples were fixed
with 10% formalin for 30 min and processed overnight using an
automatic tissue processor (ASP300, Leica, Germany). The con-
structs were embedded in paraffin wax before sectioning. 5 lm
sections were cut using a rotary microtome (Microsystems GmbH,
Germany) and sections were mounted on poly-L-lysine coated
glass slides (Thermo Scientific, Ireland). Samples were deparaf-
finised with xylene and rehydrated in descending grades of alcohol
(100% to 70%). Sections were stained in 2% alizarin red for 3 min.
Digital images of all stained sections were obtained using an imag-
ing system (AnalySIS, Nikon, Japan) in conjunction with a micro-
scope (Olympus IX51, Olympus, Japan).
2.6.3. Calcium quantification
The scaffolds were assayed for calcium deposition as a measure
of osteogenesis using a Stanbio calcium assay (Calcium CPC Liqui-
colour, Stanbio Inc., USA) following 14 and 28 days post cell seed-
ing as per manufacturers’ instructions. A Quant-iTTM PicoGreen
dsDNA assay (Invitrogen, UK) was also carried out at each time
point as described in Section 2.5.2 to normalise levels of calcium
to cell number.
2.7. Assessment of potential of collagen chitosan scaffold to support
MSC chondrogenesis
2.7.1. Chondrogenic cell culture
Cells were cultured and seeded onto scaffolds (10 mm  4 mm)
as described in Section 2.5.1. After 7 days of culture in supple-
mented DMEM growth media, growth media was replaced withPlease cite this article in press as: R.M. Raftery et al., Multifunctional biomater
lagen scaffolds on mechanical and biological functionality, Acta Biomater. (201chondrogenic media which contains high glucose DMEM supple-
mented with 1% penicillin/streptomycin, 1% non-essential amino
acids, 1% L-Glutamine, 50 lg/mL ascorbic acid, 40 lg/mL
L-proline, 100 nM dexamethasone, 1x ITS (Insulin, Transferrin,
Selenium) (BD Biosciences, UK), 0.11 mg/mL sodium pyruvate
and 20 ng/mL of transforming growth factor-b3 (TGF-b3) (Prospec,
Israel). Media was replaced every 3 days for the duration of the
assay (14 and 28 days).2.7.2. Safranin O staining for sGAG
Safranin O staining was used to investigate the level of sulfated
GAG deposition within the scaffolds, which is representative of
MSC chondrogenesis. Samples were fixed with 10% formalin for
30 min and processed overnight using an automatic tissue proces-
sor (ASP300, Leica, Germany). The constructs were embedded in
paraffin wax before sectioning. 5 lm sections were cut using a
rotary microtome (Microsystems GmbH, Germany) and sections
were mounted on poly-L-lysine coated glass slides (Thermo
Scientific, Ireland). Samples were deparaffinised with xylene and
rehydrated in descending grades of alcohol (100% to 70%). Harris
haematoxylin was used to stain cell nuclei, followed by a 0.2% Fast
Green counter stain. The samples were then stained in Safranin O
for 60 min. Digital images of all stained sections were obtained
using an imaging system (AnalySIS, Nikon, Japan) in conjunction
with a microscope (Olympus IX51, Olympus, Japan).2.7.3. sGAG quantification
Cell-seeded and cell-free control scaffolds were washed in PBS
before digesting in a solution prepared from papain enzyme solu-
tion containing 0.5 M EDTA, cysteine-HCl and 1 mg/ml papain
enzyme (Carica papaya, Sigma-Aldrich, Ireland) at 60 C for 12 h.
sGAG content was assessed using a Blyscan Sulfated Glycosamino-
glycan Assay kit (Biocolor Life Sciences, UK) following manufactur-
ers’ instructions.2.8. Statistical analysis
Results are expressed as mean ± standard deviation. Statistical
significance was assessed using two-way ANOVA analysis followed
by Bonferoni post hoc analysis. The sample size was n = 3
and p 6 0.05 values were considered statistically significant where
⁄ p < 0.05, ⁄⁄ p < 0.01 and ⁄⁄⁄ p < 0.001.3. Results
3.1. Effect of chitosan incorporation on scaffold morphology and
architecture
Scaffold pore size was quantified (Fig. 1A) and there was no
significant difference in pore size between the bovine-derived
collagen scaffolds containing chitosan at ratios of 100:0,
90:10 and 75:25 (161.1 lm ± 26.3 lm, 121.6 lm ± 4.5 lm and
130.6 lm ± 7.7 lm respectively), however when chitosan was
incorporated at a ratio of 50:50, there was a significant reduction
in pore size to 74.7 lm ± 2.3 lm (p < 0.05). In the salmon-derived
collagen groups (Fig. 1A), pore size was smallest in the scaffold
containing 100:0 ratio of collagen to chitosan (25.45 lm ± 2.4 lm)
but pore size significantly increased with the incorporation of
increasing amounts of chitosan, with a resultant pore size of
55.8 lm ± 2.3 lm, 61.8 lm ± 5.9 lm and 97.8 lm ± 12.3 lm in
the scaffolds at 90:10, 75:25 and 50:50 respectively (p < 0.01).
Overall, apart from the 50:50 group, the salmon-derived collagen
scaffolds had significantly smaller pores than the bovine-derived
collagen scaffolds (p < 0.001).ials from the sea: Assessing the effects of chitosan incorporation into col-
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Fig. 1. Effect of chitosan incorporation on scaffold morphology. Bovine and salmon-derived collagen scaffolds containing chitosan at ratios of 100:0, 90:10, 75:25 and 50:50
were assessed for pore size, porosity and porous architecture. The incorporation of chitosan into a bovine-derived collagen scaffold causes a decrease in pore size while the
opposite occurs with salmon-derived collagen scaffold groups (A). Data plotted shows mean ± standard deviation (n = 3) and p < 0.05, ⁄⁄ p < 0.01 and ⁄⁄⁄ p < 0.001. Percentage
porosity was calculated as a relative ratio of scaffold density to the density of solid collagen and chitosan. All scaffolds had mean porosity of >97% (B). Statistical significance
was measured using one-way ANOVA. Representative images of bovine and salmon-derived collagen scaffolds with increasing amounts of chitosan show porous structure
and pore interconnectivity (C). The images were taken at 9 kV at a magnification of 300x. Scale bar represents 20 lm.
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(Fig. 1B). The bovine-derived collagen scaffold had the highest level
of porosity at 99.4% and while the incorporation of chitosan caused
a slight reduction in porosity, the porosity of the 90:10, 75:25 and
50:50 collagen-chitosan scaffolds remained above 99%. The
salmon-derived collagen scaffolds had a lower overall porosity,
which increased proportionally with the addition of chitosan from
97.8% (100:0) to 98.6% (50:50). All scaffolds retained a highly por-
ous interconnected architecture as shown in representative SEM
images in Fig. 1C.
3.2. Effect of chitosan incorporation on scaffold mechanical properties
The bulk compressive modulus of each scaffold type was mea-
sured after chitosan incorporation and cross-linking with both
physical (DHT) and chemical (EDC + NHS) treatments (Fig. 2A).
The incorporation of chitosan into bovine-derived collagen scaf-
folds caused a significant increase in compressive modulus from
0.92 kPa for the collagen alone to 1.09 kPa and 1.23 kPa for the
scaffolds containing collagen-chitosan at ratios of 75:25 and
50:50, respectively (p < 0.05 for 90:10 up to p < 0.001 for 50:50).
An increase in bulk compressive modulus was also seen in the
salmon-derived collagen group; scaffolds without chitosanPlease cite this article in press as: R.M. Raftery et al., Multifunctional biomater
lagen scaffolds on mechanical and biological functionality, Acta Biomater. (201(100:0) had a low compressive modulus of 0.13 kPa but after the
incorporation of chitosan, a 3–4.5-fold increase was observed with
increasing chitosan content at 0.38 kPa, 0.39 kPa and 0.56 kPa for
90:10, 75:25 and 50:50 chitosan-containing scaffolds respectively
(p < 0.001). However, the salmon-derived collagen-chitosan scaf-
folds were significantly (50–80%) less stiff than the bovine-
derived collagen-chitosan scaffolds overall (p < 0.001).
The scaffold swelling index, or the ability of the scaffold to
absorb and retain water, was assessed by a standard swelling test.
The incorporation of chitosan to both bovine and salmon-derived
collagen scaffolds caused an increase in the hydrophillicity of the
scaffolds (p < 0.05), with the scaffolds containing a 50:50 ratio of
collagen to chitosan retaining the most water after 4 h (Fig. 2B).
The incorporation of chitosan into collagen scaffolds also affected
the scaffold degradation rate. The addition of even 90:10 chitosan
was enough to significantly prolong the degradation rate of both
bovine and salmon-derived collagen scaffolds (p < 0.001) (Fig. 2C).
However, the salmon-derived collagen scaffolds containing 50:50
collagen-chitosan disintegrated after 14 days in serum-containing
media.
Overall, the bovine-derived collagen scaffolds out-performed
the salmon-derived collagen scaffolds in each test, displaying a
larger pore size and higher percentage porosity (Fig. 1A and B),ials from the sea: Assessing the effects of chitosan incorporation into col-
6), http://dx.doi.org/10.1016/j.actbio.2016.07.009
Fig. 2. Effect of chitosan on mechanical properties of collagen scaffolds. Scaffold compressive modulus (A), swelling ratio (B) and degradation rate (C) were assessed
comparing both bovine and salmon-derived collagen-based scaffolds containing chitosan at ratios of 100:0, 90:10, 75:25 and 50:50. Unconfined uni-axial testing was carried
on scaffolds and graph A shows an increase in compressive modulus in proportion with increasing chitosan content. A standard swelling test also revealed that increasing
chitosan content causes an increase in the scaffolds hydrophilicity (B) and also prolongs the scaffolds degradation rate (C). Data plotted represents mean ± standard deviation
(n = 3) and significance is indicated with ⁄ p < 0.05, ⁄⁄ p < 0.01 and ⁄⁄⁄ p < 0.001.
6 R.M. Raftery et al. / Acta Biomaterialia xxx (2016) xxx–xxxmore regular architecture (Fig. 1C), higher compressive modulus
(Fig. 2A) and greater capacity for water uptake (Fig. 2B).3.3. Effect of chitosan incorporation on MSC viability within scaffold
To determine the effects of chitosan on cell viability and prolif-
eration on the scaffolds, DNA content was quantified after 14 and
28 days in culture and an approximate cell number was deter-
mined (Fig. 3). In the bovine-derived collagen scaffolds there was
no difference in cell growth after 14 days, however, following
28 days in culture, the bovine-derived collagen scaffolds contain-
ing 90:10 and 75:25 collagen-chitosan supported a 2.5-fold greater
number of cells compared to scaffolds containing 100:0 and 50:50
collagen-chitosan (Fig. 3A). The incorporation of chitosan into thePlease cite this article in press as: R.M. Raftery et al., Multifunctional biomater
lagen scaffolds on mechanical and biological functionality, Acta Biomater. (201salmon-derived collagen scaffold initially caused a decrease in cell
viability (Fig. 3B); however, after 28 days, there was a significantly
higher number of cells on the salmon-derived collagen scaffolds
containing 75:25 and 50:50 collagen-chitosan compared to colla-
gen alone, although this number was 2-fold lower than that seen
on the bovine-derived collagen groups.
Overall, the bovine-derived collagen scaffold composed of
collagen-chitosan at a ratio of 75:25 supported more cell prolifer-
ation than any other group. Furthermore, cell numbers on the
salmon-derived collagen-chitosan scaffolds were 50% lower than
the bovine-derived collagen-chitosan scaffolds (90:10 and 75:25).
For this reason, the bovine-derived collagen scaffold containing
75:25 ratio of collagen to chitosan was deemed the most favour-
able scaffold and was brought forward to assess its potential in
bone and cartilage tissue engineering applications.ials from the sea: Assessing the effects of chitosan incorporation into col-
6), http://dx.doi.org/10.1016/j.actbio.2016.07.009
Fig. 3. Effect of chitosan incorporation into (A) bovine and (B) salmon-derived
collagen scaffolds on MSC viability. 5X105 cells were seeded onto 10 mm diameter
discs of scaffold. After 14 and 28 days dsDNA was quantified. The dsDNA content in
5X105 cells were also assessed and cell number on the scaffolds was calculated. The
incorporation of chitosan into both bovine (A) and salmon (B) -derived collagen
scaffolds cause an increase in cell proliferation with the bovine-derived collagen
scaffold containing 75:25 collagen-chitosan supporting significantly higher cell
proliferation than other groups. Cell number on the salmon-derived collagen-
chitosan scaffolds was 50% lower than bovine collagen-chitosan scaffolds. Data
plotted shows mean ± standard deviation (n = 3) and ⁄ indicates p < 0.05, ⁄⁄ p < 0.01
and ⁄⁄⁄ p < 0.001.
Fig. 4. Assessment of osteogenic potential of collagen-chitosan scaffold. Bovine-
derived collagen scaffolds containing chitosan at ratios of 100:0 or 75:25 were
seeded with MSCs and cultured in osteogenic media for 28 days. More mineral
deposition (red) is seen with the scaffold containing 75:25 collagen-chitosan
compared to the scaffold without chitosan (100:0). When quantified, MSCs cultured
on the scaffold containing 75:25 collagen-chitosan deposited significantly more
calcium compared to collagen alone (100:0). Data plotted shows mean ± standard
deviation (n = 3) and ⁄ indicates p < 0.05, ⁄⁄ p < 0.01 and ⁄⁄⁄ p < 0.001. (For
interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
R.M. Raftery et al. / Acta Biomaterialia xxx (2016) xxx–xxx 73.4. Assessment of potential of collagen-chitosan composite scaffold to
support MSC osteogenesis
MSCs were cultured on scaffolds composed of bovine-derived
collagen-chitosan at a ratio of 75:25 and were compared to plain
collagen scaffolds (100:0). Following 14 and 28 days in culture in
osteogenic media, the scaffolds were stained with alizarin red as
a marker of cell-mediated calcium deposition. The scaffold
containing 100:0 collagen-chitosan had low levels of calcium
deposition at both time-points (Fig. 4A and C) while the scaffold
containing 75:25 collagen-chitosan (Fig. 4B and D) stained posi-
tively for mineralisation at both days 14 and 28. When calcium
content within these scaffolds was quantified (Fig. 4E), the scaffold
containing 75:25 collagen-chitosan caused the MSCs to deposit
significantly more calcium than scaffolds composed of collagen
alone (350 lg vs. 150 lg – p < 0.01).3.5. Assessment of potential of collagen-chitosan composite scaffold to
support MSC chondrogenesis
MSCs were cultured on scaffolds composed of bovine-derived
collagen-chitosan at a ratio of 75:25 and were compared to plain
collagen scaffolds (100:0). After 14 and 28 days in chondrogenic
media, the scaffolds were stained using Safranin O which stains
sulfated glycosaminoglycan (sGAG) pink. There were small
amounts of sGAG evident around the periphery of the 100:0
collagen scaffold (Fig. 5A and B) while increased levels of sGAG
can be seen in the scaffolds containing 75:25 collagen-chitosan
(Fig. 5C and D). This observation was confirmed when sGAG was
quantified showing significantly higher amounts of sGAG produc-
tion on the scaffold containing 75:25 collagen-chitosan comparedPlease cite this article in press as: R.M. Raftery et al., Multifunctional biomater
lagen scaffolds on mechanical and biological functionality, Acta Biomater. (201to the scaffold without chitosan (40 lg per lg of DNA per scaffold
compared to 10 lg per lg of DNA per scaffold – p < 0.01)
(Fig. 5E).
4. Discussion
The goal of this study was to investigate the effect of the addi-
tion of chitosan on the morphological and mechanical properties of
collagen scaffolds and also to investigate if marine-derived colla-
gen, isolated from salmon skin, might serve as a viable alternative
to mammalian-derived collagen (from the bovine tendon) in ortho-
paedic tissue engineering applications. In addition, the potential of
the resultant collagen-chitosan composite scaffold to enhance both
osteogenesis and chondrogenesis was assessed. The results of this
study demonstrated that the addition of chitosan improved the
mechanical properties of both bovine and salmon-derived collagen
scaffolds with bulk compressive modulus, swelling index andials from the sea: Assessing the effects of chitosan incorporation into col-
6), http://dx.doi.org/10.1016/j.actbio.2016.07.009
Fig. 5. Assessment of chondrogenic potential of collagen-chitosan scaffold. Bovine-
derived collagen scaffolds containing chitosan at ratios of 100:0 or 75:25 were
seeded with MSCs and cultured in chondrogenic media for 28 days. More sGAG
deposition (pink) is seen with the scaffold containing 75:25 collagen-chitosan
compared to the scaffold without chitosan. When quantified, MSCs cultured on the
scaffold containing 75:25 collagen-chitosan deposited significantly more sGAG
compared to collagen alone (100:0). Data plotted shows mean ± standard deviation
(n = 3) and ⁄ indicates p < 0.05, ⁄⁄ p < 0.01 and ⁄⁄⁄ p < 0.001. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of
this article.)
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However, overall, the bovine-derived collagen-based scaffolds
were shown to be more suitable for orthopaedic tissue engineering
than salmon-derived collagen-based scaffolds. Indeed, the bovine-
derived collagen scaffold containing 75:25 collagen-chitosan
supported both MSC osteogenesis and chondrogenesis with
significantly more calcium and sGAG deposited respectively, when
compared to collagen-alone (100:0) scaffolds. Taken together, the
ability of chitosan to alter the mechanical and biological response
of collagen scaffolds has led to the development of a biomimetic
material highly suitable for orthopaedic tissue engineering.
The addition of chitosan to the bovine-derived collagen scaffold
did not have a negative effect on scaffold architecture with all scaf-
folds retaining a highly porous interconnected microstructure.
While the addition of chitosan caused a decrease in mean pore size
in the bovine-derived collagen scaffold group, the pore size of thePlease cite this article in press as: R.M. Raftery et al., Multifunctional biomater
lagen scaffolds on mechanical and biological functionality, Acta Biomater. (201scaffold containing 75:25 collagen-chitosan was comparable to a
previously developed collagen-GAG scaffold which has already
shown success in bone tissue engineering applications [55–58].
Conversely, the incorporation of chitosan into salmon-derived col-
lagen scaffolds caused a significant increase in mean pore size with
increasing chitosan content from 90:10 to 50:50 collagen-chitosan.
However overall, the salmon-derived collagen-derived scaffolds
had a significantly lower mean pore size when compared to their
bovine collagen derived counterparts. This is likely due to the
lower density of the salmon-derived collagen which produces less
viscous collagen slurry. In this study, the same freezing rate and
heating phase was used for both bovine and salmon skin collagen.
As the salmon skin collagen produced a less viscous slurry than the
bovine collagen, the material responded differently to the freezing
and heating steps, freezing faster than the more viscous bovine col-
lagen and chitosan-containing slurries. Faster freezing leads to the
formation of smaller ice crystals and therefore, smaller pores [47].
As chitosan and collagen interact via electrostatic interactions
and hydrogen bonding, it was unsurprising that the incorporation
of chitosan into collagen scaffolds significantly increased the bulk
compressive modulus of both the bovine and salmon-derived
collagen-chitosan scaffolds [49–51,59]. However, overall the bulk
compressive modulus of the salmon-derived collagen-based
scaffolds was lower than the bovine-derived collagen group as
evidenced by a maximum stiffness of 0.56 kPa in the scaffold
containing 50:50 collagen-chitosan compared to 1.23 kPa in the
equivalent bovine-derived collagen scaffold containing 50:50
collagen-chitosan. The stiffness of a material has an effect on cell
behaviour with stiffer materials supporting MSC osteogenesis
and chondrogenesis and less stiff materials supporting differentia-
tion towards softer tissues such as skin or muscle [5]. While the
bulk compressive modulus is still orders of magnitude lower than
that of native bone or cartilage tissue, the purpose of highly porous
scaffolds is to provide temporary support and allow for cell infiltra-
tion and vascularisation and endogenous healing rather than
acting as a permanent structure [6,60]. As the salmon-derived col-
lagen scaffolds were three times less stiff than the bovine-derived
collagen scaffolds, they may prove more useful in soft tissue
regeneration applications such as skin.
A major function of GAGs in cartilage is to retain water at the
site which acts to increase the compressive resistance of cartilage.
As chitosan is also a linear polysaccharide with a similar molecular
structure to GAGs, we hypothesised that the incorporation of chi-
tosan into collagen scaffolds might increase the hydrophillicity of
the scaffold. In this study, as chitosan content was increased from
100:0 to 50:50, the ability of the scaffold to retain water increased
in both bovine and salmon-derived collagen groups. The ability of a
scaffold to retain water is an important feature when designing a
scaffold for tissue engineering as it determines cell infiltration
and proliferation. A high swelling ratio has also been shown to
promote enhanced MSC osteogenesis and chondrogenesis when
compared to scaffolds with lower swelling capacity [61,62].
One of the main limitations to using collagen-based scaffolds in
tissue engineering applications is their rapid degradation rate in
physiological conditions. While tissue engineered constructs do
not necessarily need to exactly match the native tissues mechani-
cal strength [6,60], the degradation rate must be relatively consis-
tent with the rate of new tissue formation. Natural bone healing
following fracture comprises a highly coordinated series of events
which lead to new bone formation within 25–28 days [63]. While
cross-linking the scaffolds using physical and chemical methods
can improve the degradation rate [52,53], in this study, the
interactions between collagen and chitosan materials through
electrostatic activity lead to the formation of an even more stable
construct, which degraded by 10–40% over 28 days, a big improve-
ment compared to the collagen alone scaffolds, which degraded byials from the sea: Assessing the effects of chitosan incorporation into col-
6), http://dx.doi.org/10.1016/j.actbio.2016.07.009
R.M. Raftery et al. / Acta Biomaterialia xxx (2016) xxx–xxx 990% over the same length of time [17]. There was no difference in
the degradation rate of bovine and salmon-derived collagen con-
taining 90:10 and 75:25 collagen-chitosan; however, the salmon-
derived collagen scaffold containing 50:50 collagen-chitosan lost
its structural integrity during the study. Excess electrostatic inter-
actions between collagen and chitosan can lead to denaturation of
the collagen so it may be that the improvement in mechanical
properties caused by chitosan is concentration dependent and
the addition of 50:50 chitosan to collagen is detrimental to the
structural and mechanical properties of salmon-derived collagen
chitosan composite scaffolds.
In this study, differences in cell responsewere evident depending
on chitosan content and collagen source. After 28 days in growth
media, MSC proliferation on the bovine-derived collagen scaffold
containing 75:25 collagen-chitosan was significantly higher than
any other scaffold including the scaffold without chitosan (100:0).
Increasing chitosan content in the salmon-derived collagen scaf-
folds also caused an increase in cell proliferation but not to the same
extent as the bovine-derived collagen scaffolds. Thismay be due to a
combination of factors; the salmon-derived collagen-based scaf-
folds had very small pore sizes whichmay have limited cell infiltra-
tion to the edge of the scaffold [64]. The structural integrity of the
salmon-derived collagen scaffolds was also lost over the course of
the study, likely due to the low denaturation temperature of
marine-derived collagen, preventing cells from adhering [35]. The
number of viableMSCs on the bovine-derived collagen scaffold con-
taining 75:25 collagen-chitosan was significantly higher than the
collagen scaffold without chitosan while cell viability was reduced
on the scaffold containing 50:50 collagen-chitosan. This may be
due to excess complexation between collagen and chitosan, which
can leave less sites available for cell attachment and can cause colla-
gen to denature [59]. The bovine-derived collagen scaffold com-
posed of 50:50 collagen-chitosan also had a reduced pore size
(p < 0.001), which may have inhibited cellular infiltration [64].
As the bovine-derived collagen scaffold containing 75:25
collagen-chitosan was shown to have good morphological and
mechanical properties, as well as supporting MSC attachment
and proliferation, the potential of this scaffold for bone and carti-
lage tissue engineering applications was assessed by using differ-
entiation media containing osteogenic or chondrogenic
supplements. In the osteogenesis study, chitosan proved to have
significant osteogenic potential as the levels of calcium deposited
by MSCs on the chitosan-containing scaffold (75:25) was signifi-
cantly higher than in the collagen alone scaffold (100:0). Chitosan
has previously been shown to support osteoblast proliferation and
mineralisation [65,66] and has been used to coat scaffolds to
increase osteoconductivity [67]. However, this is the first time
MSC osteogenesis has been reported on a collagen-chitosan scaf-
fold. In the chondrogenesis study, MSC-mediated sGAG production
on the collagen-chitosan scaffold (75:25) was significantly higher
than the collagen alone scaffolds (100:0). Owing to the similar
molecular structure of chitosan and glycosaminoglycans found
native to cartilage tissue, particularly hyaluronic acid, it is thought
that this is why cells behave in a similar manner on substrates
composed of each material. Therefore, not only does the addition
of chitosan improve the scaffold’s mechanical properties, the envi-
ronment presented by the scaffold containing 75:25 collagen-
chitosan closely mimics the natural environment of mesenchymal
stem cells and may lead to improved formation of bone or
cartilage-like tissue, compared to a scaffold composed of collagen
alone. Overall, the salmon-derived collagen scaffolds did not per-
form as well as the bovine-derived collagen scaffolds in this study.
However, as the salmon collagen was sourced from skin, rather
than orthopaedic tissue as is the case with the bovine collagen,
the salmon collagen may be better suited for soft tissue regenera-
tion such as skin or muscle tissue engineering.Please cite this article in press as: R.M. Raftery et al., Multifunctional biomater
lagen scaffolds on mechanical and biological functionality, Acta Biomater. (2015. Conclusion
In this study we have demonstrated that the incorporation of
chitosan into collagen scaffolds can significantly improve the scaf-
folds mechanical and biological properties. With the addition of
chitosan, the mechanical properties of the collagen scaffold are
enhanced, cell proliferation was increased, and the presence of
chitosan enhances both MSC osteogenesis and chondrogenesis.
While the salmon-derived collagen scaffolds used in this study
did not perform as well as the bovine-derived collagen scaffolds
for orthopaedic tissue engineering, further studies to optimise
the lyophilisation and cross-linking methods may lead to better
results in the future. The biomimetic bovine-derived collagen-
chitosan composite represents a versatile biomaterial platform
which is capable of being applied to both bone and cartilage tissue
engineering applications.
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